Literature DB >> 33947918

Whole genome analysis of extensively drug resistant Mycobacterium tuberculosis strains in Peru.

David Santos-Lazaro1, Ronnie G Gavilan1,2, Lely Solari1, Aiko N Vigo1, Zully M Puyen3,4.   

Abstract

Peru has the highest burden of multidrug-resistant tuberculosis in the Americas region. Since 1999, the annual number of extensively drug-resistant tuberculosis (XDR-TB) Peruvian cases has been increasing, becoming a public health challenge. The objective of this study was to perform genomic characterization of Mycobacterium tuberculosis strains obtained from Peruvian patients with XDR-TB diagnosed from 2011 to 2015 in Peru. Whole genome sequencing (WGS) was performed on 68 XDR-TB strains from different regions of Peru. 58 (85.3%) strains came from the most populated districts of Lima and Callao. Concerning the lineages, 62 (91.2%) strains belonged to the Euro-American Lineage, while the remaining 6 (8.8%) strains belonged to the East-Asian Lineage. Most strains (90%) had high-confidence resistance mutations according to pre-established WHO-confident grading system. Discordant results between microbiological and molecular methodologies were caused by mutations outside the hotspot regions analysed by commercial molecular assays (rpoB I491F and inhA S94A). Cluster analysis using a cut-off ≤ 10 SNPs revealed that only 23 (34%) strains evidenced recent transmission links. This study highlights the relevance and utility of WGS as a high-resolution approach to predict drug resistance, analyse transmission of strains between groups, and determine evolutionary patterns of circulating XDR-TB strains in the country.

Entities:  

Year:  2021        PMID: 33947918     DOI: 10.1038/s41598-021-88603-y

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  55 in total

1.  Availability, price and affordability of anti-tuberculosis drugs in Europe: a TBNET survey.

Authors:  Gunar Günther; Gabriela B Gomez; Christoph Lange; Stephan Rupert; Frank van Leth
Journal:  Eur Respir J       Date:  2014-11-13       Impact factor: 16.671

Review 2.  Whole-genome sequencing in outbreak analysis.

Authors:  Carol A Gilchrist; Stephen D Turner; Margaret F Riley; William A Petri; Erik L Hewlett
Journal:  Clin Microbiol Rev       Date:  2015-07       Impact factor: 26.132

3.  The tempo and mode of molecular evolution of Mycobacterium tuberculosis at patient-to-patient scale.

Authors:  Anita C Schürch; Kristin Kremer; Albert Kiers; Olaf Daviena; Martin J Boeree; Roland J Siezen; Noel H Smith; Dick van Soolingen
Journal:  Infect Genet Evol       Date:  2009-10-14       Impact factor: 3.342

4.  Whole-genome sequencing for prediction of Mycobacterium tuberculosis drug susceptibility and resistance: a retrospective cohort study.

Authors:  Timothy M Walker; Thomas A Kohl; Shaheed V Omar; Jessica Hedge; Carlos Del Ojo Elias; Phelim Bradley; Zamin Iqbal; Silke Feuerriegel; Katherine E Niehaus; Daniel J Wilson; David A Clifton; Georgia Kapatai; Camilla L C Ip; Rory Bowden; Francis A Drobniewski; Caroline Allix-Béguec; Cyril Gaudin; Julian Parkhill; Roland Diel; Philip Supply; Derrick W Crook; E Grace Smith; A Sarah Walker; Nazir Ismail; Stefan Niemann; Tim E A Peto
Journal:  Lancet Infect Dis       Date:  2015-06-23       Impact factor: 25.071

5.  Multidrug-resistant tuberculosis in Europe, 2010-2011.

Authors:  Gunar Günther; Frank van Leth; Sofia Alexandru; Neus Altet; Korkut Avsar; Didi Bang; Raisa Barbuta; Graham Bothamley; Ana Ciobanu; Valeriu Crudu; Manfred Davilovits; Martin Dedicoat; Raquel Duarte; Gina Gualano; Heinke Kunst; Wiel de Lange; Vaira Leimane; Cecile Magis-Escurra; Anne-Marie McLaughlin; Inge Muylle; Veronika Polcová; Emanuele Pontali; Christina Popa; Rudolf Rumetshofer; Alena Skrahina; Varvara Solodovnikova; Victor Spinu; Simon Tiberi; Piret Viiklepp; Christoph Lange
Journal:  Emerg Infect Dis       Date:  2015-03       Impact factor: 6.883

6.  Genomic diversity among drug sensitive and multidrug resistant isolates of Mycobacterium tuberculosis with identical DNA fingerprints.

Authors:  Stefan Niemann; Claudio U Köser; Sebastien Gagneux; Claudia Plinke; Susanne Homolka; Helen Bignell; Richard J Carter; R Keira Cheetham; Anthony Cox; Niall A Gormley; Paula Kokko-Gonzales; Lisa J Murray; Roberto Rigatti; Vincent P Smith; Felix P M Arends; Helen S Cox; Geoff Smith; John A C Archer
Journal:  PLoS One       Date:  2009-10-12       Impact factor: 3.240

7.  Whole-genome sequencing to delineate Mycobacterium tuberculosis outbreaks: a retrospective observational study.

Authors:  Timothy M Walker; Camilla L C Ip; Ruth H Harrell; Jason T Evans; Georgia Kapatai; Martin J Dedicoat; David W Eyre; Daniel J Wilson; Peter M Hawkey; Derrick W Crook; Julian Parkhill; David Harris; A Sarah Walker; Rory Bowden; Philip Monk; E Grace Smith; Tim E A Peto
Journal:  Lancet Infect Dis       Date:  2012-11-15       Impact factor: 25.071

8.  Genetic variability of Mycobacterium tuberculosis complex in patients with no known risk factors for MDR-TB in the North-Eastern part of Lima, Peru.

Authors:  Francesca Barletta; Larissa Otero; Jimena Collantes; Belisa Asto; Bouke C de Jong; Carlos Seas; Leen Rigouts
Journal:  BMC Infect Dis       Date:  2013-08-28       Impact factor: 3.090

Review 9.  Extensively drug-resistant tuberculosis: epidemiology and management.

Authors:  Alberto Matteelli; Alberto Roggi; Anna Cc Carvalho
Journal:  Clin Epidemiol       Date:  2014-04-01       Impact factor: 4.790

10.  Characterization of the genetic diversity of extensively-drug resistant Mycobacterium tuberculosis clinical isolates from pulmonary tuberculosis patients in Peru.

Authors:  Omar Cáceres; Nalin Rastogi; Carlos Bartra; David Couvin; Marco Galarza; Luis Asencios; Alberto Mendoza-Ticona
Journal:  PLoS One       Date:  2014-12-09       Impact factor: 3.240

View more
  3 in total

1.  In vitro anti-tuberculosis effect of probiotic Lacticaseibacillus rhamnosus PMC203 isolated from vaginal microbiota.

Authors:  Md Abdur Rahim; Hoonhee Seo; Sukyung Kim; Hanieh Tajdozian; Indrajeet Barman; Youngkyoung Lee; Saebim Lee; Ho-Yeon Song
Journal:  Sci Rep       Date:  2022-05-18       Impact factor: 4.996

2.  Structural Rigidification of N-Aryl-pyrroles into Indoles Active against Intracellular and Drug-Resistant Mycobacteria.

Authors:  Dorothy Semenya; Meir Touitou; Camila Maringolo Ribeiro; Fernando Rogerio Pavan; Luca Pisano; Vinayak Singh; Kelly Chibale; Georg Bano; Anita Toscani; Fabrizio Manetti; Beatrice Gianibbi; Daniele Castagnolo
Journal:  ACS Med Chem Lett       Date:  2021-12-08       Impact factor: 4.345

3.  High clustering rate and genotypic drug-susceptibility screening for the newly recommended anti-tuberculosis drugs among global extensively drug-resistant Mycobacterium tuberculosis isolates.

Authors:  Kanwara Trisakul; Ditthawat Nonghanphithak; Pratchakan Chaiyachat; Orawee Kaewprasert; Kankanon Sakmongkoljit; Wipa Reechaipichitkul; Angkana Chaiprasert; David Blair; Taane G Clark; Kiatichai Faksri
Journal:  Emerg Microbes Infect       Date:  2022-12       Impact factor: 19.568

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.